Title |
Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial
|
---|---|
Published in |
Trials, October 2020
|
DOI | 10.1186/s13063-020-04737-w |
Pubmed ID | |
Authors |
Ava Ziaei, Parivash Davoodian, Habib Dadvand, Omid Safa, Soheil Hassanipour, Mahmoud Omidi, Moein Masjedi, Fahime Mahmoudikia, Bahareh Rafiee, Mohammad Fathalipour |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 33% |
India | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 391 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 391 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 54 | 14% |
Researcher | 37 | 9% |
Student > Ph. D. Student | 26 | 7% |
Student > Master | 24 | 6% |
Other | 18 | 5% |
Other | 60 | 15% |
Unknown | 172 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 82 | 21% |
Nursing and Health Professions | 39 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 19 | 5% |
Psychology | 16 | 4% |
Biochemistry, Genetics and Molecular Biology | 11 | 3% |
Other | 38 | 10% |
Unknown | 186 | 48% |